Status: Recruiting
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
To evaluate the safety and efficacy of autologous hematopoietic stem cell transplantation (ASCT) combined with BCMA-CART in the treatment of UHR-MM.
Participants needed: 50
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Aug 7, 2025Locations: 1
Eligibility criteria
The subjects voluntarily participated in the study and signed the informed conse...
Have a history of allergy to any component in cell products; [+12]